SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: axial3/25/2019 9:08:47 AM
   of 250
 
PROMETIC SECURES ADDITIONAL USD $5 MILLION (CAD $6.7MILLION) TRANCHE FROM STRUCTURED ALPHA LP, AN AFFILIATEOF THOMVEST ASSET MANAGEMENT INC., UNDER ITS EXISTING CREDIT FACILITIES


'LAVAL, QUEBEC, CANADA – March 25, 2019 – Prometic Life Sciences Inc. (TSX: PLI, OTCQX: PFSCF) (“Prometic” or the “Corporation”) announced today that it has secured an additional USD $5 million (CAD $6.7 million) tranche from Structured Alpha LP (“SALP”), an affiliate of Thomvest Asset Management Inc., under the existing loan agreement originally entered into with SALP in November 2017. The proceeds of this loan extension will be used to satisfy the near-term cash requirements of the Corporation.'
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext